Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

NEAT022 Study Group

    Research output: Contribution to journal › A1: Web of Science-article › peer-review

    Fingerprint

    Dive into the research topics of 'Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk'. Together they form a unique fingerprint.

    Medicine & Life Sciences